{"id":"NCT01271933","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients","officialTitle":"A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03","primaryCompletion":"2012-07","completion":"2012-07","firstPosted":"2011-01-07","resultsPosted":"2018-09-14","lastUpdate":"2021-01-22"},"enrollment":441,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Fibromyalgia"],"interventions":[{"type":"DRUG","name":"pregabalin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Pregabalin","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of a controlled release formulation of pregabalin administered once daily as compared to placebo in the treatment of fibromyalgia. All patients will receive pregabalin; half of the patients will receive placebo at some point in the study.","primaryOutcome":{"measure":"Double-Blind Phase: Time to Loss of Therapeutic Response (LTR)","timeFrame":"Randomization to Week 19","effectByArm":[{"arm":"Pregabalin (Double Blind Phase)","deltaMin":58,"sd":null},{"arm":"Placebo (Double Blind Phase)","deltaMin":23,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0186"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":52,"countries":["United States","Canada","India","Taiwan"]},"refs":{"pmids":["24867298"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081245&StudyName=Study%20Of%20A%20Controlled%20Release%20Formulation%20Of%20Pregabalin%20In%20Fibromyalgia%20Patients"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":441},"commonTop":["Dizziness","Somnolence","Nausea","Headache","Fatigue"]}}